24.10.2022 - New Partnership will Improve and Advance CING Manufacturing OperationsKANSAS CITY, Kan., Oct. 24, 2022 (GLOBE NEWSWIRE) - Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release (PTR) drug . Seite 1
Cingulate Inc (CING) Enters Agreement with Societal CDMO and Provides Clinical Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Cingulate Announces Agreement with Societal CDMO and Provides Clinical Update
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Kansas City Business Journal Names Cingulate s Louis G Van Horn a 2022 Chief Financial Officer of the Year
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.